Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer

SIMPLE SUMMARY: There is an urgent need to improve the therapeutic options in pancreatic cancer. In this study, we assessed the ability of two standard-of-care chemotherapeutic regimens to modulate the levels of PD-L1 mRNA isolated from plasma-derived microvesicles (MVs) of patients with pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Re, Marzia, Vivaldi, Caterina, Rofi, Eleonora, Salani, Francesca, Crucitta, Stefania, Catanese, Silvia, Fontanelli, Lorenzo, Massa, Valentina, Cucchiara, Federico, Fornaro, Lorenzo, Capuano, Annalisa, Fogli, Stefano, Vasile, Enrico, Danesi, Romano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345069/
https://www.ncbi.nlm.nih.gov/pubmed/34359638
http://dx.doi.org/10.3390/cancers13153738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345069/
https://www.ncbi.nlm.nih.gov/pubmed/34359638
http://dx.doi.org/10.3390/cancers13153738

Ejemplares similares